Global Etelcalcetide Hydrochloride Injection Market Growth 2026-2032
The global Etelcalcetide Hydrochloride Injection market size is predicted to grow from US$ 392 million in 2025 to US$ 511 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.
Etelcalcetide Hydrochloride Injection is a specialty injectable product used for the treatment of secondary hyperparathyroidism in chronic kidney disease patients on hemodialysis. Pharmacologically, it is a calcium-sensing receptor agonist, or calcimimetic, and it is mainly administered intravenously by healthcare professionals after dialysis sessions. Its commercial value is mainly reflected in strong treatment manageability within the dialysis setting, specialty-care compatibility, and relatively stable long-term maintenance demand. Key upstream inputs mainly include Etelcalcetide API, injectable excipients such as sodium chloride, succinic acid, hydrochloric acid or sodium hydroxide, as well as vials, stoppers, seals, sterile filling systems, and formulation or packaging infrastructure. Downstream customers mainly include the originator's regional commercial network, specialty renal injectable manufacturers, hospitals, dialysis centers, renal specialty care institutions, and related pharmaceutical distribution channels. In 2025, the global Etelcalcetide Hydrochloride Injection market had an estimated nameplate capacity of about 27.0 million units, actual sales volume of about 19.2 million units, an average ex-factory price of about USD 20.9 per unit, and a gross margin of roughly 57%-67%. Overall, this product remains a typical renal specialty injectable with limited volume, high value-added characteristics, and strong compliance requirements. Market supply is relatively concentrated, and competition is driven more by regulatory access, supply reliability, and dialysis-channel coverage than by pure price competition.
At present, the Etelcalcetide Hydrochloride Injection market remains highly specialized, relatively concentrated, and strongly tied to fixed treatment settings. End-use demand is mainly anchored in hospital-based and dialysis-center-based care pathways rather than in retail channels or broad outpatient prescription expansion. This means the market depends heavily on dialysis-center penetration, hospital procurement systems, and nephrology prescribing habits. As a result, although the application boundary is clear, the commercial pathway is more restricted and the entry barrier is higher than that of conventional chronic-care drugs. At the same time, global supply is still centered around a limited number of commercial systems, and the product continues to benefit from its workflow fit and clinical manageability within the dialysis setting.
Looking ahead, the market is more likely to develop through gradual evolution rather than rapid volume expansion. On one hand, long-term management needs for secondary hyperparathyroidism in dialysis patients will continue to support demand, and the increasing standardization of specialty treatment pathways is favorable to maintaining the product's clinical position. On the other hand, as specialty injectable markets place more emphasis on supply security, drug accessibility, regulatory compliance, and cost control, competition is likely to shift from simple product availability to broader capabilities such as supply-chain stability, regional regulatory execution, channel coverage, and access to hospitals and dialysis centers. For manufacturers, long-term competitiveness will depend less on having the product alone and more on the ability to combine quality systems, commercial support, and regional market execution.
The major growth drivers come from persistent clinical demand and the product's strong fit with the treatment workflow. In hemodialysis patients, the management of secondary hyperparathyroidism is ongoing and highly specialized, making treatment demand continuous rather than one-time in nature. In this context, intravenous administration aligns well with post-dialysis care routines, helping improve treatment control and execution while reducing some of the uncertainties associated with oral therapy adherence and monitoring. In addition, as specialty care systems continue to emphasize treatment quality and workflow standardization, injectable products that integrate naturally into dialysis routines are more likely to maintain stable clinical use. Moreover, the need for sterile injectable manufacturing, specialty indication access, and strong compliance capabilities further reinforces market barriers and helps support the position of established suppliers.
The constraints are also significant. First, the eligible patient population is inherently limited to those receiving hemodialysis, which naturally caps the market compared with broad-based therapeutic categories. Second, market entry for specialty injectables usually requires long lead times and depends on regulatory approval, hospital listing, channel setup, and clinical adoption, so even companies with product development capability may not convert that into meaningful sales quickly. Third, as genericization gradually advances and regional competition deepens, pricing pressure, tender pressure, and supply-chain cost pressure may all intensify, creating risks for margin compression. As a result, the market is likely to see more participants over time, but only a limited number of companies will be able to build sustainable commercial positions. The long-term profile of this segment will therefore remain one of limited scale, high barriers, and strong specialty-market characteristics.
LP Information, Inc. (LPI) ' newest research report, the ?Etelcalcetide Hydrochloride Injection Industry Forecast? looks at past sales and reviews total world Etelcalcetide Hydrochloride Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Etelcalcetide Hydrochloride Injection sales for 2026 through 2032. With Etelcalcetide Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etelcalcetide Hydrochloride Injection industry.
This Insight Report provides a comprehensive analysis of the global Etelcalcetide Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etelcalcetide Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Etelcalcetide Hydrochloride Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etelcalcetide Hydrochloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etelcalcetide Hydrochloride Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Etelcalcetide Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Etelcalcetide Hydrochloride Injection is a specialty injectable product used for the treatment of secondary hyperparathyroidism in chronic kidney disease patients on hemodialysis. Pharmacologically, it is a calcium-sensing receptor agonist, or calcimimetic, and it is mainly administered intravenously by healthcare professionals after dialysis sessions. Its commercial value is mainly reflected in strong treatment manageability within the dialysis setting, specialty-care compatibility, and relatively stable long-term maintenance demand. Key upstream inputs mainly include Etelcalcetide API, injectable excipients such as sodium chloride, succinic acid, hydrochloric acid or sodium hydroxide, as well as vials, stoppers, seals, sterile filling systems, and formulation or packaging infrastructure. Downstream customers mainly include the originator's regional commercial network, specialty renal injectable manufacturers, hospitals, dialysis centers, renal specialty care institutions, and related pharmaceutical distribution channels. In 2025, the global Etelcalcetide Hydrochloride Injection market had an estimated nameplate capacity of about 27.0 million units, actual sales volume of about 19.2 million units, an average ex-factory price of about USD 20.9 per unit, and a gross margin of roughly 57%-67%. Overall, this product remains a typical renal specialty injectable with limited volume, high value-added characteristics, and strong compliance requirements. Market supply is relatively concentrated, and competition is driven more by regulatory access, supply reliability, and dialysis-channel coverage than by pure price competition.
At present, the Etelcalcetide Hydrochloride Injection market remains highly specialized, relatively concentrated, and strongly tied to fixed treatment settings. End-use demand is mainly anchored in hospital-based and dialysis-center-based care pathways rather than in retail channels or broad outpatient prescription expansion. This means the market depends heavily on dialysis-center penetration, hospital procurement systems, and nephrology prescribing habits. As a result, although the application boundary is clear, the commercial pathway is more restricted and the entry barrier is higher than that of conventional chronic-care drugs. At the same time, global supply is still centered around a limited number of commercial systems, and the product continues to benefit from its workflow fit and clinical manageability within the dialysis setting.
Looking ahead, the market is more likely to develop through gradual evolution rather than rapid volume expansion. On one hand, long-term management needs for secondary hyperparathyroidism in dialysis patients will continue to support demand, and the increasing standardization of specialty treatment pathways is favorable to maintaining the product's clinical position. On the other hand, as specialty injectable markets place more emphasis on supply security, drug accessibility, regulatory compliance, and cost control, competition is likely to shift from simple product availability to broader capabilities such as supply-chain stability, regional regulatory execution, channel coverage, and access to hospitals and dialysis centers. For manufacturers, long-term competitiveness will depend less on having the product alone and more on the ability to combine quality systems, commercial support, and regional market execution.
The major growth drivers come from persistent clinical demand and the product's strong fit with the treatment workflow. In hemodialysis patients, the management of secondary hyperparathyroidism is ongoing and highly specialized, making treatment demand continuous rather than one-time in nature. In this context, intravenous administration aligns well with post-dialysis care routines, helping improve treatment control and execution while reducing some of the uncertainties associated with oral therapy adherence and monitoring. In addition, as specialty care systems continue to emphasize treatment quality and workflow standardization, injectable products that integrate naturally into dialysis routines are more likely to maintain stable clinical use. Moreover, the need for sterile injectable manufacturing, specialty indication access, and strong compliance capabilities further reinforces market barriers and helps support the position of established suppliers.
The constraints are also significant. First, the eligible patient population is inherently limited to those receiving hemodialysis, which naturally caps the market compared with broad-based therapeutic categories. Second, market entry for specialty injectables usually requires long lead times and depends on regulatory approval, hospital listing, channel setup, and clinical adoption, so even companies with product development capability may not convert that into meaningful sales quickly. Third, as genericization gradually advances and regional competition deepens, pricing pressure, tender pressure, and supply-chain cost pressure may all intensify, creating risks for margin compression. As a result, the market is likely to see more participants over time, but only a limited number of companies will be able to build sustainable commercial positions. The long-term profile of this segment will therefore remain one of limited scale, high barriers, and strong specialty-market characteristics.
LP Information, Inc. (LPI) ' newest research report, the ?Etelcalcetide Hydrochloride Injection Industry Forecast? looks at past sales and reviews total world Etelcalcetide Hydrochloride Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Etelcalcetide Hydrochloride Injection sales for 2026 through 2032. With Etelcalcetide Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etelcalcetide Hydrochloride Injection industry.
This Insight Report provides a comprehensive analysis of the global Etelcalcetide Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etelcalcetide Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Etelcalcetide Hydrochloride Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etelcalcetide Hydrochloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etelcalcetide Hydrochloride Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Etelcalcetide Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 2.5 mg/0.5 mL
- 5 mg/1 mL
- 10 mg/2 mL
- Single-dose Vial
- Pre-filled Syringe
- Online Sales
- Offline Sales
- Hospitals
- Dialysis Centers
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Ono Pharmaceutical
- Fosun Pharma
- What is the 10-year outlook for the global Etelcalcetide Hydrochloride Injection market?
- What factors are driving Etelcalcetide Hydrochloride Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Etelcalcetide Hydrochloride Injection market opportunities vary by end market size?
- How does Etelcalcetide Hydrochloride Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Etelcalcetide Hydrochloride Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Etelcalcetide Hydrochloride Injection by Country/Region, 2021, 2025 & 2032
2.2 Etelcalcetide Hydrochloride Injection Segment by Type
2.2.1 2.5 mg/0.5 mL
2.2.2 5 mg/1 mL
2.2.3 10 mg/2 mL
2.2.4 Etelcalcetide Hydrochloride Injection Sales by Type
2.2.4.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Type (2021-2026)
2.3 Etelcalcetide Hydrochloride Injection Segment by Packaging Format
2.3.1 Single-dose Vial
2.3.2 Pre-filled Syringe
2.3.3 Etelcalcetide Hydrochloride Injection Sales by Packaging Format
2.3.3.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format (2021-2026)
2.3.3.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Packaging Format (2021-2026)
2.3.3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Packaging Format (2021-2026)
2.4 Etelcalcetide Hydrochloride Injection Segment by Sales Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Etelcalcetide Hydrochloride Injection Sales by Sales Channels
2.4.3.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels (2021-2026)
2.4.3.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Sales Channels (2021-2026)
2.4.3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Sales Channels (2021-2026)
2.5 Etelcalcetide Hydrochloride Injection Segment by Application
2.5.1 Hospitals
2.5.2 Dialysis Centers
2.5.3 Other
2.5.4 Etelcalcetide Hydrochloride Injection Sales by Application
2.5.4.1 Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2021-2026)
2.5.4.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Etelcalcetide Hydrochloride Injection Breakdown Data by Company
3.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Company (2021-2026)
3.1.2 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company (2021-2026)
3.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Etelcalcetide Hydrochloride Injection Revenue by Company (2021-2026)
3.2.2 Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company (2021-2026)
3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Etelcalcetide Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etelcalcetide Hydrochloride Injection Product Location Distribution
3.4.2 Players Etelcalcetide Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ETELCALCETIDE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Etelcalcetide Hydrochloride Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Etelcalcetide Hydrochloride Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Etelcalcetide Hydrochloride Injection Sales Growth
4.4 APAC Etelcalcetide Hydrochloride Injection Sales Growth
4.5 Europe Etelcalcetide Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Growth
5 AMERICAS
5.1 Americas Etelcalcetide Hydrochloride Injection Sales by Country
5.1.1 Americas Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
5.1.2 Americas Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
5.2 Americas Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
5.3 Americas Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etelcalcetide Hydrochloride Injection Sales by Region
6.1.1 APAC Etelcalcetide Hydrochloride Injection Sales by Region (2021-2026)
6.1.2 APAC Etelcalcetide Hydrochloride Injection Revenue by Region (2021-2026)
6.2 APAC Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
6.3 APAC Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Etelcalcetide Hydrochloride Injection by Country
7.1.1 Europe Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
7.1.2 Europe Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
7.2 Europe Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
7.3 Europe Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Etelcalcetide Hydrochloride Injection by Country
8.1.1 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etelcalcetide Hydrochloride Injection
10.3 Manufacturing Process Analysis of Etelcalcetide Hydrochloride Injection
10.4 Industry Chain Structure of Etelcalcetide Hydrochloride Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etelcalcetide Hydrochloride Injection Distributors
11.3 Etelcalcetide Hydrochloride Injection Customer
12 WORLD FORECAST REVIEW FOR ETELCALCETIDE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Etelcalcetide Hydrochloride Injection Market Size Forecast by Region
12.1.1 Global Etelcalcetide Hydrochloride Injection Forecast by Region (2027-2032)
12.1.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Etelcalcetide Hydrochloride Injection Forecast by Type (2027-2032)
12.7 Global Etelcalcetide Hydrochloride Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.1.3 Amgen Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Ono Pharmaceutical
13.2.1 Ono Pharmaceutical Company Information
13.2.2 Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.2.3 Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ono Pharmaceutical Main Business Overview
13.2.5 Ono Pharmaceutical Latest Developments
13.3 Fosun Pharma
13.3.1 Fosun Pharma Company Information
13.3.2 Fosun Pharma Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.3.3 Fosun Pharma Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fosun Pharma Main Business Overview
13.3.5 Fosun Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Etelcalcetide Hydrochloride Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Etelcalcetide Hydrochloride Injection by Country/Region, 2021, 2025 & 2032
2.2 Etelcalcetide Hydrochloride Injection Segment by Type
2.2.1 2.5 mg/0.5 mL
2.2.2 5 mg/1 mL
2.2.3 10 mg/2 mL
2.2.4 Etelcalcetide Hydrochloride Injection Sales by Type
2.2.4.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Type (2021-2026)
2.3 Etelcalcetide Hydrochloride Injection Segment by Packaging Format
2.3.1 Single-dose Vial
2.3.2 Pre-filled Syringe
2.3.3 Etelcalcetide Hydrochloride Injection Sales by Packaging Format
2.3.3.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format (2021-2026)
2.3.3.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Packaging Format (2021-2026)
2.3.3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Packaging Format (2021-2026)
2.4 Etelcalcetide Hydrochloride Injection Segment by Sales Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Etelcalcetide Hydrochloride Injection Sales by Sales Channels
2.4.3.1 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels (2021-2026)
2.4.3.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Sales Channels (2021-2026)
2.4.3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Sales Channels (2021-2026)
2.5 Etelcalcetide Hydrochloride Injection Segment by Application
2.5.1 Hospitals
2.5.2 Dialysis Centers
2.5.3 Other
2.5.4 Etelcalcetide Hydrochloride Injection Sales by Application
2.5.4.1 Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2021-2026)
2.5.4.2 Global Etelcalcetide Hydrochloride Injection Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Etelcalcetide Hydrochloride Injection Breakdown Data by Company
3.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Company (2021-2026)
3.1.2 Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company (2021-2026)
3.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Etelcalcetide Hydrochloride Injection Revenue by Company (2021-2026)
3.2.2 Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company (2021-2026)
3.3 Global Etelcalcetide Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Etelcalcetide Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etelcalcetide Hydrochloride Injection Product Location Distribution
3.4.2 Players Etelcalcetide Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ETELCALCETIDE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Etelcalcetide Hydrochloride Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Etelcalcetide Hydrochloride Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Etelcalcetide Hydrochloride Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Etelcalcetide Hydrochloride Injection Sales Growth
4.4 APAC Etelcalcetide Hydrochloride Injection Sales Growth
4.5 Europe Etelcalcetide Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Growth
5 AMERICAS
5.1 Americas Etelcalcetide Hydrochloride Injection Sales by Country
5.1.1 Americas Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
5.1.2 Americas Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
5.2 Americas Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
5.3 Americas Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etelcalcetide Hydrochloride Injection Sales by Region
6.1.1 APAC Etelcalcetide Hydrochloride Injection Sales by Region (2021-2026)
6.1.2 APAC Etelcalcetide Hydrochloride Injection Revenue by Region (2021-2026)
6.2 APAC Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
6.3 APAC Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Etelcalcetide Hydrochloride Injection by Country
7.1.1 Europe Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
7.1.2 Europe Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
7.2 Europe Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
7.3 Europe Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Etelcalcetide Hydrochloride Injection by Country
8.1.1 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etelcalcetide Hydrochloride Injection
10.3 Manufacturing Process Analysis of Etelcalcetide Hydrochloride Injection
10.4 Industry Chain Structure of Etelcalcetide Hydrochloride Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etelcalcetide Hydrochloride Injection Distributors
11.3 Etelcalcetide Hydrochloride Injection Customer
12 WORLD FORECAST REVIEW FOR ETELCALCETIDE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Etelcalcetide Hydrochloride Injection Market Size Forecast by Region
12.1.1 Global Etelcalcetide Hydrochloride Injection Forecast by Region (2027-2032)
12.1.2 Global Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Etelcalcetide Hydrochloride Injection Forecast by Type (2027-2032)
12.7 Global Etelcalcetide Hydrochloride Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.1.3 Amgen Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Ono Pharmaceutical
13.2.1 Ono Pharmaceutical Company Information
13.2.2 Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.2.3 Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ono Pharmaceutical Main Business Overview
13.2.5 Ono Pharmaceutical Latest Developments
13.3 Fosun Pharma
13.3.1 Fosun Pharma Company Information
13.3.2 Fosun Pharma Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
13.3.3 Fosun Pharma Etelcalcetide Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fosun Pharma Main Business Overview
13.3.5 Fosun Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Etelcalcetide Hydrochloride Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Etelcalcetide Hydrochloride Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5 mg/0.5 mL
Table 4. Major Players of 5 mg/1 mL
Table 5. Major Players of 10 mg/2 mL
Table 6. Global Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Table 8. Global Etelcalcetide Hydrochloride Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Etelcalcetide Hydrochloride Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Single-dose Vial
Table 12. Major Players of Pre-filled Syringe
Table 13. Global Etelcalcetide Hydrochloride Injection Sales by Packaging Format (2021-2026) & (K Units)
Table 14. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format (2021-2026)
Table 15. Global Etelcalcetide Hydrochloride Injection Revenue by Packaging Format (2021-2026) & ($ million)
Table 16. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Packaging Format (2021-2026)
Table 17. Global Etelcalcetide Hydrochloride Injection Sale Price by Packaging Format (2021-2026) & (US$/Unit)
Table 18. Major Players of Online Sales
Table 19. Major Players of Offline Sales
Table 20. Global Etelcalcetide Hydrochloride Injection Sales by Sales Channels (2021-2026) & (K Units)
Table 21. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Etelcalcetide Hydrochloride Injection Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Etelcalcetide Hydrochloride Injection Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Global Etelcalcetide Hydrochloride Injection Sale by Application (2021-2026) & (K Units)
Table 26. Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2021-2026)
Table 27. Global Etelcalcetide Hydrochloride Injection Revenue by Application (2021-2026) & ($ million)
Table 28. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Application (2021-2026)
Table 29. Global Etelcalcetide Hydrochloride Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Etelcalcetide Hydrochloride Injection Sales by Company (2021-2026) & (K Units)
Table 31. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company (2021-2026)
Table 32. Global Etelcalcetide Hydrochloride Injection Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company (2021-2026)
Table 34. Global Etelcalcetide Hydrochloride Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Etelcalcetide Hydrochloride Injection Producing Area Distribution and Sales Area
Table 36. Players Etelcalcetide Hydrochloride Injection Products Offered
Table 37. Etelcalcetide Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Etelcalcetide Hydrochloride Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Etelcalcetide Hydrochloride Injection Sales Market Share Geographic Region (2021-2026)
Table 42. Global Etelcalcetide Hydrochloride Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Etelcalcetide Hydrochloride Injection Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2021-2026)
Table 46. Global Etelcalcetide Hydrochloride Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 49. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Country (2021-2026)
Table 50. Americas Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 52. Americas Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 53. APAC Etelcalcetide Hydrochloride Injection Sales by Region (2021-2026) & (K Units)
Table 54. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Region (2021-2026)
Table 55. APAC Etelcalcetide Hydrochloride Injection Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 57. APAC Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 58. Europe Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 59. Europe Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 61. Europe Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Etelcalcetide Hydrochloride Injection
Table 67. Key Market Challenges & Risks of Etelcalcetide Hydrochloride Injection
Table 68. Key Industry Trends of Etelcalcetide Hydrochloride Injection
Table 69. Etelcalcetide Hydrochloride Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Etelcalcetide Hydrochloride Injection Distributors List
Table 72. Etelcalcetide Hydrochloride Injection Customer List
Table 73. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Etelcalcetide Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Etelcalcetide Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Amgen Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Amgen Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 89. Amgen Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Ono Pharmaceutical Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 94. Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Ono Pharmaceutical Main Business
Table 96. Ono Pharmaceutical Latest Developments
Table 97. Fosun Pharma Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Fosun Pharma Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 99. Fosun Pharma Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Fosun Pharma Main Business
Table 101. Fosun Pharma Latest Developments
Table 1. Etelcalcetide Hydrochloride Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Etelcalcetide Hydrochloride Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5 mg/0.5 mL
Table 4. Major Players of 5 mg/1 mL
Table 5. Major Players of 10 mg/2 mL
Table 6. Global Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Table 8. Global Etelcalcetide Hydrochloride Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Etelcalcetide Hydrochloride Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Single-dose Vial
Table 12. Major Players of Pre-filled Syringe
Table 13. Global Etelcalcetide Hydrochloride Injection Sales by Packaging Format (2021-2026) & (K Units)
Table 14. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format (2021-2026)
Table 15. Global Etelcalcetide Hydrochloride Injection Revenue by Packaging Format (2021-2026) & ($ million)
Table 16. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Packaging Format (2021-2026)
Table 17. Global Etelcalcetide Hydrochloride Injection Sale Price by Packaging Format (2021-2026) & (US$/Unit)
Table 18. Major Players of Online Sales
Table 19. Major Players of Offline Sales
Table 20. Global Etelcalcetide Hydrochloride Injection Sales by Sales Channels (2021-2026) & (K Units)
Table 21. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Etelcalcetide Hydrochloride Injection Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Etelcalcetide Hydrochloride Injection Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Global Etelcalcetide Hydrochloride Injection Sale by Application (2021-2026) & (K Units)
Table 26. Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2021-2026)
Table 27. Global Etelcalcetide Hydrochloride Injection Revenue by Application (2021-2026) & ($ million)
Table 28. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Application (2021-2026)
Table 29. Global Etelcalcetide Hydrochloride Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Etelcalcetide Hydrochloride Injection Sales by Company (2021-2026) & (K Units)
Table 31. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company (2021-2026)
Table 32. Global Etelcalcetide Hydrochloride Injection Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company (2021-2026)
Table 34. Global Etelcalcetide Hydrochloride Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Etelcalcetide Hydrochloride Injection Producing Area Distribution and Sales Area
Table 36. Players Etelcalcetide Hydrochloride Injection Products Offered
Table 37. Etelcalcetide Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Etelcalcetide Hydrochloride Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Etelcalcetide Hydrochloride Injection Sales Market Share Geographic Region (2021-2026)
Table 42. Global Etelcalcetide Hydrochloride Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Etelcalcetide Hydrochloride Injection Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2021-2026)
Table 46. Global Etelcalcetide Hydrochloride Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 49. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Country (2021-2026)
Table 50. Americas Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 52. Americas Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 53. APAC Etelcalcetide Hydrochloride Injection Sales by Region (2021-2026) & (K Units)
Table 54. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Region (2021-2026)
Table 55. APAC Etelcalcetide Hydrochloride Injection Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 57. APAC Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 58. Europe Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 59. Europe Etelcalcetide Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 61. Europe Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Etelcalcetide Hydrochloride Injection
Table 67. Key Market Challenges & Risks of Etelcalcetide Hydrochloride Injection
Table 68. Key Industry Trends of Etelcalcetide Hydrochloride Injection
Table 69. Etelcalcetide Hydrochloride Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Etelcalcetide Hydrochloride Injection Distributors List
Table 72. Etelcalcetide Hydrochloride Injection Customer List
Table 73. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Etelcalcetide Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Etelcalcetide Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Etelcalcetide Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Etelcalcetide Hydrochloride Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Etelcalcetide Hydrochloride Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Amgen Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Amgen Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 89. Amgen Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Ono Pharmaceutical Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 94. Ono Pharmaceutical Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Ono Pharmaceutical Main Business
Table 96. Ono Pharmaceutical Latest Developments
Table 97. Fosun Pharma Basic Information, Etelcalcetide Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Fosun Pharma Etelcalcetide Hydrochloride Injection Product Portfolios and Specifications
Table 99. Fosun Pharma Etelcalcetide Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Fosun Pharma Main Business
Table 101. Fosun Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Etelcalcetide Hydrochloride Injection
Figure 2. Etelcalcetide Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etelcalcetide Hydrochloride Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Etelcalcetide Hydrochloride Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Etelcalcetide Hydrochloride Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2025)
Figure 10. Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5 mg/0.5 mL
Figure 12. Product Picture of 5 mg/1 mL
Figure 13. Product Picture of 10 mg/2 mL
Figure 14. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type in 2026
Figure 15. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Single-dose Vial
Figure 17. Product Picture of Pre-filled Syringe
Figure 18. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format in 2026
Figure 19. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Packaging Format (2021-2026)
Figure 20. Product Picture of Online Sales
Figure 21. Product Picture of Offline Sales
Figure 22. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels in 2026
Figure 23. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Etelcalcetide Hydrochloride Injection Consumed in Hospitals
Figure 25. Global Etelcalcetide Hydrochloride Injection Market: Hospitals (2021-2026) & (K Units)
Figure 26. Etelcalcetide Hydrochloride Injection Consumed in Dialysis Centers
Figure 27. Global Etelcalcetide Hydrochloride Injection Market: Dialysis Centers (2021-2026) & (K Units)
Figure 28. Etelcalcetide Hydrochloride Injection Consumed in Other
Figure 29. Global Etelcalcetide Hydrochloride Injection Market: Other (2021-2026) & (K Units)
Figure 30. Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2025)
Figure 31. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Application in 2025
Figure 32. Etelcalcetide Hydrochloride Injection Sales by Company in 2025 (K Units)
Figure 33. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company in 2025
Figure 34. Etelcalcetide Hydrochloride Injection Revenue by Company in 2025 ($ millions)
Figure 35. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company in 2025
Figure 36. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 39. Americas Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 40. APAC Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 41. APAC Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 42. Europe Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 43. Europe Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 46. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Country in 2025
Figure 47. Americas Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 48. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 49. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 50. United States Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Region in 2025
Figure 55. APAC Etelcalcetide Hydrochloride Injection Revenue Market Share by Region (2021-2026)
Figure 56. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 57. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 58. China Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. India Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Country in 2025
Figure 66. Europe Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 67. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 68. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 69. Germany Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. France Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 77. Egypt Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Etelcalcetide Hydrochloride Injection in 2026
Figure 83. Manufacturing Process Analysis of Etelcalcetide Hydrochloride Injection
Figure 84. Industry Chain Structure of Etelcalcetide Hydrochloride Injection
Figure 85. Channels of Distribution
Figure 86. Global Etelcalcetide Hydrochloride Injection Sales Market Forecast by Region (2027-2032)
Figure 87. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Etelcalcetide Hydrochloride Injection Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Etelcalcetide Hydrochloride Injection Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Etelcalcetide Hydrochloride Injection
Figure 2. Etelcalcetide Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etelcalcetide Hydrochloride Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Etelcalcetide Hydrochloride Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Etelcalcetide Hydrochloride Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2025)
Figure 10. Etelcalcetide Hydrochloride Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5 mg/0.5 mL
Figure 12. Product Picture of 5 mg/1 mL
Figure 13. Product Picture of 10 mg/2 mL
Figure 14. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Type in 2026
Figure 15. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Single-dose Vial
Figure 17. Product Picture of Pre-filled Syringe
Figure 18. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Packaging Format in 2026
Figure 19. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Packaging Format (2021-2026)
Figure 20. Product Picture of Online Sales
Figure 21. Product Picture of Offline Sales
Figure 22. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Sales Channels in 2026
Figure 23. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Etelcalcetide Hydrochloride Injection Consumed in Hospitals
Figure 25. Global Etelcalcetide Hydrochloride Injection Market: Hospitals (2021-2026) & (K Units)
Figure 26. Etelcalcetide Hydrochloride Injection Consumed in Dialysis Centers
Figure 27. Global Etelcalcetide Hydrochloride Injection Market: Dialysis Centers (2021-2026) & (K Units)
Figure 28. Etelcalcetide Hydrochloride Injection Consumed in Other
Figure 29. Global Etelcalcetide Hydrochloride Injection Market: Other (2021-2026) & (K Units)
Figure 30. Global Etelcalcetide Hydrochloride Injection Sale Market Share by Application (2025)
Figure 31. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Application in 2025
Figure 32. Etelcalcetide Hydrochloride Injection Sales by Company in 2025 (K Units)
Figure 33. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Company in 2025
Figure 34. Etelcalcetide Hydrochloride Injection Revenue by Company in 2025 ($ millions)
Figure 35. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Company in 2025
Figure 36. Global Etelcalcetide Hydrochloride Injection Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Etelcalcetide Hydrochloride Injection Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 39. Americas Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 40. APAC Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 41. APAC Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 42. Europe Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 43. Europe Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Etelcalcetide Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 46. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Country in 2025
Figure 47. Americas Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 48. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 49. Americas Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 50. United States Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Region in 2025
Figure 55. APAC Etelcalcetide Hydrochloride Injection Revenue Market Share by Region (2021-2026)
Figure 56. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 57. APAC Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 58. China Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. India Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Country in 2025
Figure 66. Europe Etelcalcetide Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 67. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 68. Europe Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 69. Germany Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. France Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Etelcalcetide Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 77. Egypt Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Etelcalcetide Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Etelcalcetide Hydrochloride Injection in 2026
Figure 83. Manufacturing Process Analysis of Etelcalcetide Hydrochloride Injection
Figure 84. Industry Chain Structure of Etelcalcetide Hydrochloride Injection
Figure 85. Channels of Distribution
Figure 86. Global Etelcalcetide Hydrochloride Injection Sales Market Forecast by Region (2027-2032)
Figure 87. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Etelcalcetide Hydrochloride Injection Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Etelcalcetide Hydrochloride Injection Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Etelcalcetide Hydrochloride Injection Revenue Market Share Forecast by Application (2027-2032)
